Tong H H, Park J H, Brady T, Weghorst C M, D'Ambrosio S M
Division of Radiobiology, The College of Medicine, The Ohio State University, Columbus 43221, USA.
Environ Mol Mutagen. 1997;29(2):168-79.
O6-Alkylguanine-DNA alkyltransferase (AGT) is responsible for repairing the O6-alkylguanine lesion in DNA. There is wide variation in the levels of AGT between organ and cell types, which appears to correlate with cell and tissue type sensitivity to the mutagenic and carcinogenic effects of alkylating agents. In order to investigate the role of AGT in modulating the frequency and types of mutations induced in one type of normal human parenchymal cells, we examined the types and frequency of mutations in the hypoxanthine (guanine) phosphoribosyltransferase (hprt gene in 116 mutants derived from two N-ethyl-N-nitrosourea (ENU)-treated normal human skin keratinocyte cell lines. O6-Benzylguanine (O6-BZ; 5 microM x 2 hours) was used to specifically inhibit AGT activity before ENU treatment (0 to 5 mM x 1 hour). O6-BZ increased both the cytotoxic and mutagenic effects of ENU by 1.8- and 3- to 5-fold, respectively. In both treatment groups, most of the mutations were base substitutions (72%). The proportion of GC to AT transitions in the O6-BZ group (14/31) was twice that in the group treated with ENU alone, consistent with the loss of AGT activity in these cells. There was no strand specificity of GC to AT and AT to GC transitions in both groups. Base transversions accounted for 28% of total base substitutions. A lower than expected proportion of AT to TA transversions were observed in both cell lines, which decreased in the O6-BZ pretreated group. A strand bias was observed for GC to TA and AT to TA transversions. Most of the G to A and G to T base substitutions had one or more purines flanking 3' to the mutated deoxyguanosines. There were more deletion mutants with the deletion of exon 1, 4, 6, and 8 in the BZ group than in the control group. These data, characterizing the mutational spectra of ENU in normal human keratinocytes treated in vitro, indicate that GC to AT and AT to GC transition mutations predominate in these cells depleted or not depleted of AGT.
O6-烷基鸟嘌呤-DNA烷基转移酶(AGT)负责修复DNA中的O6-烷基鸟嘌呤损伤。AGT在不同器官和细胞类型中的水平存在很大差异,这似乎与细胞和组织类型对烷化剂诱变和致癌作用的敏感性相关。为了研究AGT在调节一种正常人类实质细胞中诱导的突变频率和类型方面的作用,我们检测了来自两个经N-乙基-N-亚硝基脲(ENU)处理的正常人类皮肤角质形成细胞系的116个突变体中次黄嘌呤(鸟嘌呤)磷酸核糖基转移酶(hprt基因)的突变类型和频率。在ENU处理(0至5 mM×1小时)之前,使用O6-苄基鸟嘌呤(O6-BZ;5 microM×2小时)特异性抑制AGT活性。O6-BZ分别使ENU的细胞毒性和诱变作用增加了1.8倍和3至5倍。在两个处理组中,大多数突变都是碱基替换(72%)。O6-BZ组中GC到AT转换的比例(14/31)是单独用ENU处理组的两倍,这与这些细胞中AGT活性的丧失一致。两组中GC到AT和AT到GC转换均无链特异性。碱基颠换占总碱基替换的28%。在两个细胞系中均观察到低于预期比例的AT到TA颠换,在O6-BZ预处理组中该比例降低。对于GC到TA和AT到TA颠换观察到链偏向。大多数G到A和G到T碱基替换在突变的脱氧鸟苷3'侧翼有一个或多个嘌呤。BZ组中缺失外显子1、4、6和8的缺失突变体比对照组更多。这些表征体外处理的正常人类角质形成细胞中ENU突变谱的数据表明,在AGT耗尽或未耗尽的这些细胞中,GC到AT和AT到GC转换突变占主导。